Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
about
Catecholaminergic polymorphic ventricular tachycardia: An exciting new eraSK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmiasPharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.Cardiotoxicity screening: a review of rapid-throughput in vitro approaches.Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats
P2860
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
@ast
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
@en
type
label
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
@ast
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
@en
prefLabel
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
@ast
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
@en
P2093
P2860
P1433
P1476
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
@en
P2093
Asher Shainberg
Christine E Seidman
Dan Aravot
Edith Hochhauser
Efrat Kurtzwald-Josefson
Jonathan G Seidman
Katia Bogachenko
Michael Arad
Michael Eldar
P2860
P304
P356
10.1016/J.HRTHM.2014.04.030
P577
2014-04-21T00:00:00Z